Effects of oral alendronate on BMD in adult patients with osteogenesis imperfecta: a 3-year randomized placebo-controlled trial. [electronic resource]
Producer: 20060403Description: 300-6 p. digitalISSN:- 0884-0431
- Absorptiometry, Photon
- Administration, Oral
- Adult
- Alendronate -- administration & dosage
- Biomarkers -- blood
- Bone Density -- drug effects
- Bone Density Conservation Agents -- administration & dosage
- Bone Remodeling
- Collagen -- blood
- Collagen Type I
- Female
- Fractures, Bone -- diagnostic imaging
- Hearing Loss -- diagnosis
- Hip -- diagnostic imaging
- Humans
- Lumbar Vertebrae -- diagnostic imaging
- Male
- Middle Aged
- Osteogenesis Imperfecta -- drug therapy
- Pain -- diagnosis
- Peptides -- blood
- Placebos
- Spinal Fractures -- diagnostic imaging
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.